Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Benedicta Thompson"'
Autor:
Peter Appiah–Thompson, Benedicta Thompson, Olukemi Olawaiye Dampson, Paul Masiowski, Yaw Asante Awuku
Publikováno v:
British Journal of Medicine and Medical Research. 10:1-5
Myasthenia gravis (MG) is a chronic neuromuscular junction (NMJ) dysfunction with a wide spectrum of neurological manifestations. MG is as a result of autoantibodies directed against NMJ at the postsynaptic level involving nicotinic or other postsyna
Autor:
Matilda Ayim-Akonor, Christa Ehmen, Jürgen May, Benedicta Thompson, Robin Kobbe, Iris Langefeld, Samuel Adjei, Peter Apiah-Thompson, Christina Kreuzberg, Ohene Adjei, Benno Kreuels
Publikováno v:
Blood. 115(22)
The high prevalence of hemoglobin S (HbS) in Africa and hemoglobin C (HbC) in parts of West Africa is caused by the strong protection against severe falciparum malaria during childhood. Much less is known about the effect of HbS and especially HbC on
Autor:
Christina Kreuzberg, Christian Meyer, Peter Apia Thompson, Benno Kreuels, Ernest Cudjoe Opoku, Ohene Adjei, Nadine Schreiber, Wibke Busch, Meral Tosun, Benedicta Thompson, Florian Marks, Robin Kobbe, Juergen May, Samuel Adjei
Publikováno v:
Malaria Journal
Malaria Journal, Vol 6, Iss 1, p 163 (2007)
Malaria Journal, Vol 6, Iss 1, p 163 (2007)
Background Intermittent preventive antimalarial treatment in infants (IPTi) is currently evaluated as a malaria control strategy. Among the factors influencing the extent of protection that is provided by IPTi are the transmission intensity, seasonal
Autor:
Robin Kobbe, Jürgen May, Wibke Busch, Matilda Ayim, Kwado Amoah, Benno Kreuels, Ernest Cudjoe Opoku, Ohene Adjei, Benedicta Thompson, Iris Langefeld, Peter Apia Thompson, Samuel Adjei, Harry Hoffman Abruquah, Florian Marks, Christina Kreuzberg, Christian Meyer
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 45(1)
Intermittent preventive antimalarial treatment in infants (IPTi) with sulfadoxine-pyrimethamine reduces falciparum malaria and anemia but has not been evaluated in areas with intense perennial malaria transmission. It is unknown whether an additional